Research focus
About the research
How can nanomedicine contribute to new nanoparticle drug delivery systems for pancreas cancer?
Read the full research overview
Andre Nel is a Distinguished Professor of Medicine and is Founder and Chief of the Division of Nanomedicine. He is the Director of the University of California's Center for Environmental Implications of Nanotechnology. He also directs a National Cancer Institute funded Center to study new nanoparticle drug delivery systems. He previously directed the Center for Nanobiology and Predictive Toxicology, which focuses on human inhalation toxicology.
Selected publications
3 listedCombination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1
Advanced Science
Use of a Liver-Targeting Immune-Tolerogenic mRNA Lipid Nanoparticle Platform to Treat Peanut-Induced Anaphylaxis by Single- and Multiple-Epitope Nucleotide Sequence Delivery
ACS Nano
Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs
ACS Nano
People & alumni
Team details haven’t been added. See the lab’s website for its current members.
Alumni details haven’t been added. Check the lab’s official website.
Sources & listing information
Find Research Labs maintains this page using public sources. The faculty member, lab, and university have not claimed or approved this listing. Listing a lab does not indicate endorsement, partnership, or a recruiting opportunity.
Request a correction or removal ↗ · About directory listings